Explore patent oppositions filed by Sintetica against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 24, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3977993Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZEROct 29, 2024
EP3191461Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-BenzoxazolePFIZERAug 3, 2022
EP2962690(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPEOct 15, 2019

Explore Sintetica's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 24, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4231996Sep 18, 2024Ready To Use, Noradrenaline Drip Bags, Having Low Subvisible Particle Counts1
EP4051251Aug 23, 2023Stable, Injectable Noradrenaline Solutions Free Of Antioxidants1
EP3110399Jan 10, 2018Process For Producing A Stable Low Concentration, Injectable Solution Of Noradrenaline1